statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	199
SG - Singapore	154
CN - Cina	134
IT - Italia	93
HK - Hong Kong	51
BR - Brasile	42
NL - Olanda	31
FR - Francia	20
IN - India	19
RU - Federazione Russa	19
DE - Germania	15
GB - Regno Unito	15
SE - Svezia	15
CI - Costa d'Avorio	14
FI - Finlandia	13
AT - Austria	7
ES - Italia	7
MX - Messico	7
CA - Canada	6
JP - Giappone	6
ID - Indonesia	5
IQ - Iraq	5
PL - Polonia	5
TR - Turchia	5
VN - Vietnam	5
BE - Belgio	4
ZA - Sudafrica	4
IE - Irlanda	3
PT - Portogallo	3
TW - Taiwan	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AR - Argentina	1
AU - Australia	1
AZ - Azerbaigian	1
CH - Svizzera	1
CL - Cile	1
CO - Colombia	1
CU - Cuba	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
EC - Ecuador	1
GR - Grecia	1
LA - Repubblica Popolare Democratica del Laos	1
LK - Sri Lanka	1
LT - Lituania	1
LV - Lettonia	1
MA - Marocco	1
PE - Perù	1
PH - Filippine	1
PK - Pakistan	1
PY - Paraguay	1
SA - Arabia Saudita	1
UA - Ucraina	1
Totale	933

Nome	#
Emergency Department and Out-of-Hospital Emergency System (112-AREU 118) integrated response to Coronavirus Disease 2019 in a Northern Italy centre	181
Long-term dynamics of natural killer cells in response to SARS-CoV-2 vaccination: Persistently enhanced activity postvaccination	174
High‐throughput peptide array analysis and computational techniques for serological profiling of flavivirus infections: Implications for diagnostics and vaccine development	124
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection	103
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy	96
Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit	89
Immunity to SARS-CoV-2 up to 15 months after infection	88
Serum and breastmilk SARS-CoV-2 specific antibodies following BNT162b2 vaccine: prolonged protection from SARS-CoV-2 in newborns and older children	58
Performance of VivaDiag COVID‐19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID‐19 in acute patients referring to emergency room department	51
Totale	964

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	8	0	0	0	0	0	1	0	3	3	0	1	0
2021/2022	32	1	1	0	0	3	0	1	1	3	3	2	17
2022/2023	33	5	4	1	2	4	6	1	3	1	0	5	1
2023/2024	37	0	0	3	0	4	2	0	0	2	7	7	12
2024/2025	437	32	27	17	35	29	19	21	42	27	54	53	81
2025/2026	411	80	70	80	90	55	36	0	0	0	0	0	0
Totale													964

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca